Shady drugmaker sold DIY weight-loss drug marked for animal use, suit alleges
Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...
Sanofi in Exclusive Talks With CD&R Over Sale of $17 Billion Opella
PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...
Sarepta Therapeutics: Strong Buy Recommendation Driven by Expanding Elevidys Sales and Promising Pipeline
Sarepta Therapeutics (SRPT) has received a new Buy rating, initiated by Jefferies analyst, Andrew Tsai. Andrew Tsai has given his Buy rating ...
WCJB1d
Artist builds giant spider for Halloween out of Amazon boxes, reclaimed items in Newberry
Alachua County residents may notice a frightening sight after an artist constructed an eight-legged freak out of cardboard ...
BioPharma Dive1d
Sanofi moves ahead with CD&R deal for stake in consumer business
Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance taking a minority 2% position.
Sarepta a new buy at Jefferies on muscular dystrophy franchise, pipeline
Jefferies initiates buy coverage on Sarepta Therapeutics (SRPT) due to Duchenne muscular dystrophy franchise and strong ...
FiercePharma1d
Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella
Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...
Zacks.com on MSN1d
Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale
Sanofi SNY has entered into exclusive negotiations with U.S.-based private equity company Clayton Dubilier & Rice (CD&R) for ...